Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX)
CPRX Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
21.80%
Analyst Rating:
HOLD
Analyst Forecast (1yr):
-49.60%
CPRX Stock Analysis
CPRX
PE Ratio:
18
CPRX
PEG Ratio:
1.1
CPRX
Forward EPS Growth (12 month):
15.90%
CPRX
PS Ratio:
6.4
CPRX
PSG Ratio:
0.6
CPRX
Forward Revenue Growth (12 month):
11.20%
CPRX Articles
No data was found